首页 | 本学科首页   官方微博 | 高级检索  
检索        

RANKL与骨代谢
引用本文:张志梅,李玉坤.RANKL与骨代谢[J].中华骨质疏松和骨矿盐疾病杂志,2010,3(1):59-63.
作者姓名:张志梅  李玉坤
作者单位:河北医科大学第三医院内分泌二科,石家庄,050051
基金项目:河北省自然科学基金项目,河北省医学适用技术跟踪项目
摘    要:核因子κB受体活化因子配基(receptor activator of NF-κB Ligand,RANKL)是一种Ⅱ型跨膜蛋白,是目前发现的惟一具有诱导破骨细胞分化、发育、发挥功能的因子。NF-κB受体激活子(receptor activatorof NF-κB,RANK)是一种Ⅰ型跨膜蛋白,是RANKL的惟一受体,是RANKL发挥功能的关键。骨保护蛋白(osteoprotegerin,OPG)是一种分泌型糖蛋白,与RANKL竞争性与RANK结合抑制骨吸收、促进骨形成。近年来通过许多对RANKL的研究发现,它不仅在骨质疏松症的发病中起重要作用,而且也在骨代谢过程中受多种因素影响,并为骨质疏松症及其他骨骼疾病的治疗开辟了广阔的前景。

关 键 词:RANKL  RANK  OPG  denosumab

RANKL and bone metabolism
ZHANG Zhi-mei,LI Yu-kun.RANKL and bone metabolism[J].Chinese Journal of Osteoporosis and Bone Mineral Research,2010,3(1):59-63.
Authors:ZHANG Zhi-mei  LI Yu-kun
Institution:( The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China)
Abstract:Receptor activator of NF-KB Ligand, a type II transmembrane protein, is so far the only one factor that can induce differentiation, maturation of osteoclastgenesis and mediating its function. Receptor activator of NF-t~B, a type ] transmembrane protein, is the unique receptor of RANKL, and it is very key for RANKL to educe function. Osteo- protegerin is a secretary glucoprotein which can link to RANK and inhibit bone resorption, enhance bone formation. Recently, many studies indicate that RANKL can not only play an important role in the pathogenesis of osteoporosis, but al- so be influenced by many factors, and open up broad prospect for the therapy of osteoporosis and other bone diseases.
Keywords:RANKL  RANK  OPG  denosumab
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号